CDK4/6 inhibitors as neoadjuvant treatment in breast cancer—what can we learn?

Title
CDK4/6 inhibitors as neoadjuvant treatment in breast cancer—what can we learn?
Authors
Keywords
-
Journal
ANNALS OF ONCOLOGY
Volume 29, Issue 12, Pages 2274-2278
Publisher
Oxford University Press (OUP)
Online
2018-10-10
DOI
10.1093/annonc/mdy456

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation